Consensus document of the Spanish Association of Gastroenterology on sedoanalgesia in digestive endoscopy;Documento de consenso de la Asociación Española de Gastroenteología sobre sedoanalgesia en la endoscopia digestiva

Gastroenterologia y Hepatologia

Volumn 29, Issue 3, 2006, Pages 131-149

  Simon M A ^a   Bordas, J M ^b   Campo, R ^c   Gonzalez Huix F ^d   Igea, F ^e   Mones J ^f  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Servicio de Oncología Médica   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e HOSPITAL RÍO CARRIÓN   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BENZODIAZEPINE; DIAZEPAM; FENTANYL; FLUMAZENIL; HYPNOTIC AGENT; MIDAZOLAM; MORPHINE; NALOXONE; OPIATE; PETHIDINE; PROPOFOL; REMIFENTANIL;

ANALGESIA; CONSENSUS; DIGESTIVE TRACT ENDOSCOPY; HUMAN; HYPOTENSION; HYPOXEMIA; MEDICAL SOCIETY; PHLEBITIS; REVIEW; SEDATION; SINUS TACHYCARDIA; SPAIN;

EID: 33645328814     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13085143     Document Type: Article

References (95)

1. Cohen J. Conscious sedation for gastrointestinal endoscopy. Recomendations. Up to date 2004;12(3).
2. Bell GD, McCloy RF, Charlton JE, Campbell, et al. Recomendation for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut. 1991;32:823-7.
3. ASGE training committee. Guidelines for training in patient monitoring and sedation and analgesia. Gastrointest Endosc. 2004;60:167-72.
4. Jung M, Hofmann C, Kiesslich R, Brakertz A. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam. Endoscopy. 2000;32:233-8.
5. Werhmann T, Kokapick S, Lembcke B, Caspary WF, Seifert H. Efficacy and safety of intravenous propofol sedation for routine ERCP: a prospective, controlled study. Gastrointest Endosc. 1999;46:677-83.
6. Vargo JJ, Zucaro G, Dumot JA, et al. Gastroenterologist administered propofol versus meperidine and midazolam for advanced upper endoscopy a prospective, randomized trial. Gastroenterology. 2002;123:8-16.
7. Lazzaroni M, Porro GB. Preparation, premedication, and surveillance. Endoscopy. 2005;37:101-9.
8. Gross JB, Bailey PL, Connis RT, Coté CJ, Davis FG, Epstein BS, et al. Practice guidelines for sedation and analgesia by nonanesthesiologists. Anesthesiology. 2002;96:1004-17.
9. Faigel DO, Baron T, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, et al. ASGE Standards of Practice Comité. Guidelines for the use of deep sedation and anestesia for gastrointestinal endoscopy. Gastrointest Endosc. 2002;56:613-7.
10. Vargo JJ. Propofol: a gastroenterologist's perspective. Gastrointest Endoscopy Clin N Am. 2004;14:313-23.
11. Chutkan R, Cohen J, Abedi M, Cruz-Correa M, Dominitz J, Gersin K, et al. Training guideline for use of propofol in gastrointestinal endoscopy. Gastrointest Endosc. 2004;60:167-72.
12. Sipe BW, Rex DK, Latinovich D, Overley C, Kinser K, Bratcher L, et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc. 2002;55:815-25.
13. Vargo JJ, Zuccaro G Jr, Dumot JA, et al. Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series. Gastrointest Endosc. 2000;52:250-5.
14. Rex DK, Overley C, Kinser K, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol. 2002;97:1159-63.
15. Heuss LT, Schniepper P, Dewe J, et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc. 2003;57:664-71.
16. Yusoff IF, Raymond G, Sahai AV. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc. 2004;60:356-60.
17. Rudner R, Jalowiecki P, Kawecki P, Gonciarz M, Mularczyk A, Petelenz M. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous ansthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointet Endosc. 2003;657-63.
18. Külling D, Rothenbühler R, Inauen W. Safety of nonanesthesist sedation with propofol for outpatient colonoscopy and esofhagogastroduodenoscopy. Endoscopy. 2003;35:679-82.
19. Cohen LB, Dubovsky AN, Aisenberg J, Miller K. Propofol for endoscopic sedation: a protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc. 2003;58: 725-32.
20. Cohen LB, Hightower ChD, Wood DA, Miller KM, Aisenberg J. Moderate leves sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc. 2004:795-803.
21. Paspatis GA, Manolaraki M, Xirouchakis G, Papanikolaou N, Chlouverakis G, Gritzali A. Synergistic sedation with midazolam propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study. Am J Gastroenterology. 2002; 97:1963-7.
22. Koshy G, Nair S, Norkus EP, Hertan HI, Pitchumoni CS. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. Am J Gastroenterol. 2000;95:1476-9.
23. Gonzalez-Huix F, Aldeguer X, Fort E, Salinas E, Figa M, Hombrados M, et al. Sedation without anesthesiologist in 5250 endoscopic procedures: midazolam vs. midazolam + dolantine vs. propofol. Gastrointest Endosc. 2004;59:AB133.
24. Ulmer BJ, Hansen JJ, Overley CA, et al. Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopist. Clin Gastroenterol Hepatol. 2003;1:425-32.
25. Külling D, Bauerfeind P, Fried M, Biro P. Patient controlled analgesia and sedation in gastrointestinal endoscoy. Gastrointest Endoscopy Clin N Am. 2004;14:353-68.
26. Vargo JJ, Eisen GM, Faigel DO, Holub J, Liebermann DA. Anestesiologist or non-anestesiologist-administered propofol and cardiopulmonary complications for endoscopy: which is safer? Gastrointestinal Endoscopy. 2004;59:AB93.
27. Heuss LT, Schniepper P, Drewe J, Pflimlin E, Beglinger C. Conscious sedation with propofol in elderly patients: a prospective evaluation. Aliment Pharmacol Ther. 2003;17:1493-501.
28. Etzom KP, Diab F, Brown RD, et al. Endoscopic retrograde cholangiopancreatography under general anesthesia: indications and results. Gastrointest Endosc. 1998;47:363-7.
29. Rozen P, Ratan J, Gilat T. Fentanyl-droperidol neuroleptanalgesia in gastrointestinal endoscopy. Gastrointest Endosc. 1997;23:142-4.
30. Wilcox CM, Forsmark CE, Cello JP. Utility of droperidol for conscious sedation in gastrointestinal procedures. Gastrointest Endosc. 1990;36:112-5.
31. Cohen J, Haber GB, Dorais JA, et al. A randomized double-blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc. 2000;51:546-51.
32. Walker JA, MacIntyre RD, Schleinitz PF, Jacobson KN, Haulk AA, Adesman PW, et al. Nurse-administered propofol sedation without anaesthesia specialist in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroenterol. 2003;98:1744-50.
33. Koshy G, Nair S, Norkus EP, Hertan HI, Pitchumoni CS, et al. Propofol versus midazolam and meperidine for conscous sedation in GI endoscopy. Am J Gastroenterol. 2000;95:1476-9.
34. Bhardwaj G, Conlon S, Bowles J, Baralt J. Use of midazolam and propofol during colonoscopy: 7 years of experience. Am J Gastroenterol. 2002;97:495-7.
35. Rex DK, Overley C, Kinser K, Coates M, Lee A, Goodwine BW, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol. 2002;97:1159-63.
36. Heuss LT, Schnieper P, Drewe J, Pfimlin E, Beglinger C. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc. 2003;57:664-71.
37. Leffler TM. Propofol for sedation in the endoscopy setting: nursing considerations for patient care. Gastroenterol Nurs. 2004; 27:176-80.
38. Waring JP, Baron TH, Hirota WK, Goldstein JL, Jacobson BC, Leighton JA, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc. 2003;58:317-22.
39. ASGE Standards of Practice Committee. Sedation and monitoring of patients undergoing gastrointestinal endoscopic procedures. Gastrointestinal Endosc. 1995;42:626-9.
40. Smith I, White PF, Nathanson M, Gouldson R. Propofol: and update on its clinical use. Anesthesiology. 1994;81:1005-43.
41. Frossard JL, Spahr L, Queneau PE. Erythromicin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized controlled double blind trial. Gastroenterology. 2002;123:17-23.
42. Greff M. Colorectal cancer screening in France: guidelines and professional reality. Endoscopy. 1999;31:471.
43. Eckardt VF, Kanzler G, Schmitt T, Eckardt AJ, Bernhard G. Complications and adverse effects of colonoscopy with selective sedation Gastrointest Endosc. 1999;49:560-5.
44. Froehlich F, Schwizer W, Thorens J, et al. Conscious sedation for gastroscopy: patient tolerante and and cardiorespiratory parameters. Gastroenterology. 1995;108:697-704.
45. Campo R, Montserrat A, Brullet E. Transnasal gastroscopy compared to conventional gastroscopy: a randomized study of feasibility, safety, and tolerance. Endoscopy. 1998;30:448-52.
46. Bru C, Pares A, Planas R. Repercusión cardiorrespiratoria de la fibrogastroscopia de urgencia. Gastroenterol Hepatol. 1983;80: 847-9.
47. O'Connor KW, Jones S. Oxygen desaturation is common and clinically underappreciated during elective endoscopic procedures. Gastrointest Endosc. 1990;36:S2-S4.
48. Bilotta JJ, Floyd JL, Waye JD. Arterial oxygen desaturation during ambulatory colonoscopy. Predictability, incidente and clinical significance. Gastrointest Endosc. 1990;36:S5-S8.
49. Bell GD, Sown S, Morden A, Coady T, Logan RF. Prevention of hipoxaemia during upper gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet. 1987;1:1022-4.
50. Griffin SM, Chung SC, Leung JWC, Li AK. Effect of intranasal oxygen on hypoxia and tachycardia during endoscopic cholangiopancreatography. BMJ. 1990;300:83-4.
51. Wang CY, Ling LC, Cardosa MS, Wong AK, Wong NW. Hypoxia during upper gastrointestinal endoscopy with and without sedation and effect of pre-oxygenation on oxygen saturation. Anesthesia. 2000;55:654-8.
52. Rosenberg J, Stausholm K, Andersen IB, Pedersen MH, Brinch K, Rasmussen V, et al. No effect of oxygen therapy on myocardial ischaemia during gastroscopy. Scand J Gastroenterol. 1996;31:200-5.
53. Vargo J, Zuccaro G, Dumot JA, Conwell DL, Morrow JB, Shay SS. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc. 2002;55:826-31.
54. Soma Y, Saito H, Kishibe T, et al. Evaluation of topical pharingeal anestesia for upper endoscopy including factors associated with patient tolerante. Gastrointest Endosc. 2001;53:14-8.
55. Zakko SF, Seifert HA, Gross JB. A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study. Gastrointest Endosc. 1999;49:684-9.
56. Keeffe EB, O'Connor KW. 1989 ASGE survey of endoscopic sedation and monitoring practices. Gastrointest Endosc. 1990; 36:S13-S8.
57. Froehlich F, Thorens J, Schwizer W, et al. Sedation and analgesia for colonoscopy: patient tolerante pain and cardiorespiratory parameters. Gastrointest Endosc. 1997;45:1-9.
58. Laluna L, Allen ML, Dimarino AJ. The comparison of midazolam and topical lidocaine spray versus the combination of midazolam, meperidine and topical lidocaine spray to sedate patients for upper endoscopy. Gastrointest Endosc. 2001;53:289-93.
59. Bartelsman JF, Sars PR, Tytgat GN. Flumazenil used for reversal of midazolam-induced sedation in endoscopy outpatients. Gastrointest Endosc. 990;36:S9-S12.
60. Chang AC, Solinger MA, Yang DT, Chen YK. Impact of flumazenil on recovery after outpatient endoscopy: a placebo-controlled trial. Gastrointest Endosc. 1999;49:573-9.
61. Wille RT, Chaffee BW, Ryan ML, Elta GH, Walter V, Barnett JL. Pharmacoeconomic evaluation of flumazenil for routine outpatient EGD. Gastrointest Endosc. 2000;51:282-7.
62. Council on Scientific Affaire, American Medical Association. The use of pulse oximetry during conscious sedation. JAMA. 1993;270:1463-8.
63. Quine MA, Bell GD, McCloy RF, Charlton JE, Devlin HB, Hopkins A. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut. 1995;36:462-7.
64. Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc. 1991;37:421-7.
65. Kawar P, Dundee JW. Frequency of pain on injection and venous sequelae following the I.V. administration of certain anaesthetics and sedatives. J Anaesth. 1982;54:935-9.
66. Teres J, Cecilia A, Bordas JM, et al. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton Nachlas tube. Gastroenterology. 1978;75:566-9.
67. Sefiert H, Schmittt T, Gultekin T, Caspary WF, Wehrmann T. sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study. Aliment Pharmacol Ther. 2000;14:1207-14.
68. Karan SB, Bailey PL. Update and review of moderate and deep sedation. Gastrointest Endoscopy Clin N Am. 2004;14:289-312.
69. Fanti L, Agostoni M, Casati A, Guslandi M, Giollo P, Torri G, et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc. 2004;60:361-6.
70. Takahashi Y, Tanaka H, Kinjo M, Sakumoto K. Sedation-free colonoscopy. Dis Colon Rectum. 2005;48:855-9.
71. Takahashi Y, Tanaka H, Kinjo M, Sakumoto K. Prospective evaluation of factors predicting diffculty and pain during sedation-free colonoscopy. Dis Colon Rectum. 2005;48:1295-300.
72. Radaelli F, Terrazzi V, Minoli G. Extended/advanced monitoring techniques in gastrointestinal endoscopy. Gastrointest Endoscopy Clin N Am. 2004;14:335-52.
73. Trojan J, Saunders BP, Wolshynowych M, Debinsky HS, Williams CB. Immediate recovery of psychomotor function after patient-administered nitrous oxide/oxygen inhalations for colonoscopy. Endoscopy. 1997;29:17-22.
74. Gan TJ, Glass PS, Winsor A, et al, and the BIS Utility Study group. Biespectral index monitoring allows faster emergency and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology. 1997;87:808-15.
75. Song D, Joshi GP, Whithe PF. Tritiation of volatile anesthesics using biespectral index facilitates recovery alter ambulatory anestesia. Anesthesiology. 1997;87:842-8.
76. Kearse LA, Rosow C, Zaslavsky A, et al. Biespectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hipnosis. Anesthesiology. 1998;88:25-34.
77. Wehrmann T, Grotkamp J, Stergiou N, Riphaus A, Kluge A, Lembcke B, et al. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc. 2002;56:817-24.
78. Jurell KR, O'Connor KW, Slack J, Fraiz J, Shaar CJ, Kent L, et al. Effect of supplemental oxygen on cardiopulmonary changes during gastrointestinal endoscopy. Gastrointest Endosc. 1994;40:665-70.
79. Horn E, Nesbit SA. Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endoscopy Clin N Am. 2004;14:247-68.
80. Marinella JA. Propofol for sedation in the intensive care unit: essentials for the clinician. Respir Med. 1997;91:505-10.
81. Diprivan 1%. Package insert. Wilmington: Astra-Zeneca; 2003.
82. Bryson HM, Fulton BR, Faulds D. Propofol: un update of its use in anaesthesia and conscious sedation. Drus. 1995;50:513-9.
83. Propofol. Package insert. New Providence: Baxter Pharmaceutical Products; 2003.
84. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (diprivan). Br J Anaesth. 1988;60:146-50.
85. nd ed. Seattle: IASP Press; 1994.
86. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adults. Crit Care Med. 2002;30:119-41.
87. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: a critical review and proposal for long-term dosing. J Pain Symptom Manage. 2001;22:672-87.
88. Glass PSA, Egan TD. A review of the pharmacokinetics and pharmacodynamics of remifentanil Anesth Analg. 1999;89:S7-S14.
89. Burkle H, Dumar S, Van Aken H. Remifentanil: a novel, shorth-acting opioid. Anesth Analg. 1996;83:646-51.
90. Martínez-Palli G, Bordas JM, Llach J, Giner A, López A, Gambus P, et al. Sedo-analgesia in colonoscopy: prospective study comparing propofol-remiphentanyl (PR), phentanyl-midazolam (PM) and eperidine-midazolam (MM). Gastrointest Endosc. 2005;61:AB109.
91. Willey J, Vargo JJ, Connor JT, Dumot JA, Conwell DL, Zuccaro G. Quantitative assessment of psicomotor recovery alter sedation and analgesia for outpatient. Gastrointest Endosc. 2002;56:810-6.
92. Koniaris LG, Wilson S, Drugas G, Simmons W. Capnographic monitoring of ventilatory status during moderate (conscious) sedation. Surg Endosc. 2003;17:1261-5.
93. Carrasco G. Instruments for monitoring intensive care unit sedation. Crit Care. 2000;4:217-25.
94. Miner JR, Bachman A, Kosman L, Teng B, Heegaard W, Biros MH. Assessment of the onset and persistence of amnesia during procedural sedation with propofol. Acad Emerg Med. 2005;12:491-6.
95. Heuss LT, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland. Endoscopy. 2005;37:161-6.